Enterome is a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut microbiome impacting human health. Enterome's success is based on its unique ability to identify small proteins and peptides ("effectors") from gut bacteria that can deliver a therapeutic benefit in humans.
| Website | http://www.enterome.com |
| Revenue | $33.8 million |
| Funding | $126.4 million |
| Employees | View employees |
| Address | 94-96 Ave Ledru-Rollin, Paris, Ile-de-France 75011, FR |
| Phone | +33 1 75 77 27 85 |
| Industry | Drug Manufacturing & Research, Medical Testing & Clinical Laboratories, Pharmaceuticals, Healthcare |
| Competitors | Seres Therapeutics, Evelo Biosciences, Ferring Pharmaceuticals, Serimmune Inc., Kintai Therapeutics, CureVac, Zymeworks Inc., Elysium Health, MEDiSYN Systems, Inc., Zymergen, Inc. +50 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 62151 Companies, NAICS Code 32541 Companies, NAICS Code 621 Companies, NAICS Code 32 Companies, NAICS Code 6215 Companies, NAICS Code 62 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Enterome SA employee's phone or email?
Enterome SA Questions
The Enterome SA annual revenue was $33.8 million in 2026.
Enterome SA is based in Paris, Ile-de-France.
The NAICS codes for Enterome SA are [62151, 32541, 621, 32, 6215, 62, 3254, 325].
The SIC codes for Enterome SA are [28, 283].
